<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26">
 <mixed-citation publication-type="journal">
  <collab>The IMpact-RSV Study Group</collab>
  <article-title>Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants</article-title>
  <source>Pediatrics</source>
  <year>1998</year>
  <volume>102</volume>
  <issue>3 Pt1</issue>
  <fpage>531</fpage>
  <lpage>537</lpage>
 </mixed-citation>
</ref>
